The stability test of the reagents that are used in vaccine manufacturing is essential for the clinical trials. There are 2 active trials using the materials tested.
Ended Purchase Order Awarded Last action
- Contract number
- 75N91020P00588
- Awardee
-
Polypeptide Laboratories San Diego, LLC UEI KULKXN9J6PF9
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $14,000
Award facts
- Contract value 100% obligated
- $14,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92126, USA
- Legislative mandates
-
- Davis-Bacon Act FAR subpart 22.4
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a purchase order to Polypeptide Laboratories San Diego, LLC for $14,000 on July 6, 2020. Work will be performed in San Diego, California. The order procures stability testing of reagents used in vaccine manufacturing to support two active clinical trials, with firm fixed price terms and an ultimate completion date of August 5, 2020.
Quick answers
Who was awarded contract 75N91020P00588?
75N91020P00588 was awarded to Polypeptide Laboratories San Diego, LLC by National Cancer Institute (National Institutes of Health) on July 6, 2020.
How much is contract 75N91020P00588 worth?
The government has obligated $14,000 on 75N91020P00588.
Was contract 75N91020P00588 competed?
The extent of competition for 75N91020P00588 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award